OrbiMed’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-269,300
Closed -$48.3M 128
2024
Q4
$48.3M Buy
269,300
+113,300
+73% +$23.1M 0.99% 29
2024
Q3
$35.7M Buy
+156,000
New +$33.6M 0.65% 46
2018
Q3
Sell
-463,300
Closed -$51.6M 160
2018
Q2
$51.6M Sell
463,300
-309,600
-40% -$36.3M 0.62% 48
2018
Q1
$91.5M Buy
772,900
+598,100
+342% +$71M 1.13% 30
2017
Q4
$19.8M Sell
174,800
-494,200
-74% -$52.8M 0.25% 80
2017
Q3
$74.2M Buy
+669,000
New +$75.3M 0.71% 43

Other funds holding UHS

OrbiMed's UHS Position: Q1 2025 in Review

OrbiMed sold out of Universal Health Services (UHS) in Q1 2025, closing a stake of 269,300 shares — an estimated $48.3M sold.

OrbiMed first reported a position in UHS in Q3 2017 and held it in 6 quarters. The position peaked at $91.5M in Q1 2018. 617 funds tracked by Wall St. Rank hold UHS as of Q1 2025.

  • OrbiMed reported no remaining Universal Health Services position as of Q1 2025 after selling out during the quarter.
  • OrbiMed sold 269,300 Universal Health Services shares in Q1 2025, an estimated $48.3M.
  • OrbiMed first reported a position in Universal Health Services in Q3 2017 and held it in 6 quarters.
  • OrbiMed's Universal Health Services position peaked at $91.5M in Q1 2018.
  • 617 funds tracked by Wall St. Rank held Universal Health Services as of Q1 2025.

Based on OrbiMed's 13F filing for Q1 2025, filed 15 May 2025.